According to Protalix BioTherapeutics 's latest financial reports the company's current revenue (TTM ) is โฌ53.21 Million. In 2024 the company made a revenue of โฌ51.31 Million a decrease over the revenue in the year 2023 that were of โฌ59.24 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.